e1 References 1 Proulx F, Fayon M, Farrell CA, Lacroix J, Gauthier M Epidemiol ogy of sepsis and multiple organ dysfunction syndrome in children Chest 1996 109(4) 1033 1037 2 Watson RS, Carcillo JA, L[.]
e1 References Proulx F, Fayon M, Farrell CA, Lacroix J, Gauthier M Epidemiology of sepsis and multiple organ dysfunction syndrome in children Chest 1996:109(4):1033-1037 Watson RS, Carcillo JA, Linde-Zwirble WT, Clermont G, Lidicker J, Angus DC The epidemiology of severe sepsis in children in the United States Am J Respir Crit Care Med 2003:167(5):695-701 Hartman ME, Linde-Zwirble WT, Angus DC, Watson RS Trends in the epidemiology of pediatric severe sepsis Pediatr Crit Care Med 2013:14(7):686-693 Czaja AS, Zimmerman JJ, Nathens AB Readmission and late mortality after pediatric severe sepsis Pediatrics 2009;123(3):849-857 Schlapbach LJ, Straney L, Alexander J, et al Mortality related to invasive infections, sepsis, and septic shock in critically ill children in Australia and New Zealand, 2002-13: a multicentre retrospective cohort study Lancet Infect Dis 2015:15(1):46-54 Weiss SL, Fitzgerald JC, Pappachan J, et al Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study Am J Respir Crit Care Med 2015 Goldstein B, Giroir B, Randolph A International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics Pediatr Crit Care Med 2005:6(1):2-8 Vermunt LC, Buysse CM, Aarsen FK, et al Long-term cognitive functioning in children and adolescents who survived septic shock caused by Neisseria meningitidis Br J Clin Psychol 2009:48(Pt 2): 195-208 Conlon NP, Breatnach C, O’Hare BP, Mannion DW, Lyons BJ Health-related quality of life after prolonged pediatric intensive care unit stay Pediatr Crit Care Med 2009:10(1):41-44 10 Knoester H, Bronner MB, Bos AP, Grootenhuis MA Quality of life in children three and nine months after discharge from a paediatric intensive care unit: a prospective cohort study Health Qual Life Outcomes 2008:6:21 11 Pollack MM, Holubkov R, Glass P, et al Functional status scale: new pediatric outcome measure Pediatrics 2009;124(1):e18-e28 12 Killien EY, Farris RWD, Watson RS, Dervan LA, Zimmerman JJ Health-related quality of life among survivors of pediatric sepsis Pediatr Crit Care Med 2019:20(6):501-509 13 Singer M, Deutschman CS, Seymour CW, et al The third international consensus definitions for sepsis and septic shock (Sepsis-3) JAMA 2016:315(8):801-810 14 Matics TJ, Sanchez-Pinto LN Adaptation and validation of a pediatric sequential organ failure assessment score and evaluation of the sepsis-3 definitions in critically ill children JAMA Pediatr 2017:171(10):e172352 15 Edlich RF, Cross CL, Dahlstrom JJ, Long WB 3rd Modern concepts of the diagnosis and treatment of purpura fulminans J Environ Pathol Toxicol Oncol 2008:27(3):191-196 16 Ceneviva G, Paschall JA, Maffei F, Carcillo JA Hemodynamic support in fluid-refractory pediatric septic shock Pediatrics 1998:102(2):e19 17 Brierley J, Peters MJ Distinct hemodynamic patterns of septic shock at presentation to pediatric intensive care Pediatrics 2008;122(4): 752-759 18 Typpo KV, Petersen NJ, Hallman DM, Markovitz BP, Mariscalco MM Day multiple organ dysfunction syndrome is associated with poor functional outcome and mortality in the pediatric intensive care unit Pediatr Crit Care Med 2009:10(5):562-570 19 Wilkinson JD, Pollack MM, Ruttimann UE, Glass NL, Yeh TS Outcome of pediatric patients with multiple organ system failure Crit Care Med 1986:14(4):271-274 20 Proulx F, Joyal JS, Mariscalco MM, Leteurtre S, Leclerc F, Lacroix J The pediatric multiple organ dysfunction syndrome Pediatr Crit Care Med 2009:10(1):12-22 21 Schlapbach LJ, Straney L, Bellomo R, MacLaren G, Pilcher D Prognostic accuracy of age-adapted SOFA, SIRS, PELOD-2, and qSOFA for in-hospital mortality among children with suspected infection admitted to the intensive care unit Intensive Care Med 2018:44(2):179-188 22 Hotchkiss RS, Karl IE The pathophysiology and treatment of sepsis N Engl J Med 2003:348(2):138-150 23 Hotchkiss RS, Coopersmith CM, McDunn JE, Ferguson TA The sepsis seesaw: tilting toward immunosuppression Nat Med 2009:15(5):496-497 24 Marshall JC, Charbonney E, Gonzalez PD The immune system in critical illness Clin Chest Med 2008:29(4):605-616, vii 25 Mira JC, Gentile LF, Mathias BJ, et al Sepsis pathophysiology, chronic critical illness, and persistent inflammation-immunosuppression and catabolism syndrome Crit Care Med 2017:45(2): 253-262 26 Hawkins RB, Raymond SL, Stortz JA, et al Chronic critical illness and the persistent inflammation, immunosuppression, and catabolism syndrome Front Immunol 2018:9:1511 27 Tapping RI Innate immune sensing and activation of cell surface Toll-like receptors Semin Immunol 2009:21(4):175-184 28 Akira S Innate immunity to pathogens: diversity in receptors for microbial recognition Immunol Rev 2009:227(1):5-8 29 Wheeler DS, Zingarelli B, Wheeler WJ, Wong HR Novel pharmacologic approaches to the management of sepsis: targeting the host inflammatory response Recent Pat Inflamm Allergy Drug Discov 2009:3(2):96-112 30 Zingarelli B, Sheehan M, Wong HR Nuclear factor-kappaB as a therapeutic target in critical care medicine Crit Care Med 2003: 31(1 suppl):S105-S111 31 Abraham E Alterations in cell signaling in sepsis Clin Infect Dis 2005:41(suppl 7):S459-S464 32 Cornell TT, Shanley TP Signal transduction overview Crit Care Med 2005:33(12 suppl):S410-S413 33 Shanley TP, Vasi N, Denenberg A, Wong HR The serine/threonine phosphatase, PP2A: endogenous regulator of inflammatory cell signaling J Immunol 2001:166(2):966-972 34 Cornell TT, Hinkovska-Galcheva V, Sun L, et al Ceramide-dependent PP2A regulation of TNFalpha-induced IL-8 production in respiratory epithelial cells Am J Physiol Lung Cell Mol Physiol 2009: 296(5):L849-L856 35 Mannel DN, Echtenacher B TNF in the inflammatory response Chem Immunol 2000:74:141-161 36 Lorente JA, Marshall JC Neutralization of tumor necrosis factor in preclinical models of sepsis Shock 2005:24(suppl 1):107-119 37 Dinarello CA Interleukin-1beta Crit Care Med 2005:33(12 suppl):S460-S462 38 Calandra T, Gerain J, Heumann D, Baumgartner JD, Glauser MP High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines The Swiss-Dutch J5 Immunoglobulin Study Group Am J Med 1991:91(1):23-29 39 Akira S, Taga T, Kishimoto T Interleukin-6 in biology and medicine Adv Immunol 1993:54:1-78 40 Osuchowski MF, Connett J, Welch K, Granger J, Remick DG Stratification is the key: inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis Crit Care Med 2009:37(5):1567-1573 41 Reinhart K, Menges T, Gardlund B, et al Randomized, placebocontrolled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study Crit Care Med 2001:29(4):765-769 42 Zlotnik A, Yoshie O Chemokines: a new classification system and their role in immunity Immunity 2000:12(2):121-127 43 Strieter RM, Kunkel SL, Keane MP, Standiford TJ Chemokines in lung injury: Thomas A Neff Lecture Chest 1999:116(1 suppl): S103-S110 44 Wong HR, Cvijanovich N, Wheeler DS, et al Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock Am J Respir Crit Care Med 2008:178(3):276-282 45 Calandra T, Froidevaux C, Martin C, Roger T Macrophage migration inhibitory factor and host innate immune defenses against bacterial sepsis J Infect Dis 2003:187(suppl 2):S385-S390 e2 46 Calandra T, Roger T Macrophage migration inhibitory factor: a regulator of innate immunity Nat Rev Immunol 2003:3(10):791-800 47 Tschoeke SK, Oberholzer A, Moldawer LL Interleukin-18: a novel prognostic cytokine in bacteria-induced sepsis Crit Care Med 2006:34(4):1225-1233 48 Opal SM, DePalo VA Anti-inflammatory cytokines Chest 2000:117(4):1162-1172 49 Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A Interleukin-10 and the interleukin-10 receptor Annu Rev Immunol 2001:19:683-765 50 Hall MW, Gavrilin MA, Knatz NL, Duncan MD, Fernandez SA, Wewers MD Monocyte mRNA phenotype and adverse outcomes from pediatric multiple organ dysfunction syndrome Pediatr Res 2007:62(5):597-603 51 Monneret G, Finck ME, Venet F, et al The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration Immunol Lett 2004;95(2):193-198 52 Wang H, Ward MF, Sama AE Novel HMGB1-inhibiting therapeutic agents for experimental sepsis Shock 2009:32(4):348-357 53 Wang H, Bloom O, Zhang M, et al HMG-1 as a late mediator of endotoxin lethality in mice Science 1999;285(5425):248-251 54 Bianchi ME HMGB1 loves company J Leukoc Biol 2009:86(3): 573-576 55 Bianchi ME DAMPs, PAMPs and alarmins: all we need to know about danger J Leukoc Biol 2007:81(1):1-5 56 Wheeler DS, Fisher LE Jr, Catravas JD, Jacobs BR, Carcillo JA, Wong HR Extracellular hsp70 levels in children with septic shock Pediatr Crit Care Med 2005:6(3):308-311 57 Wheeler DS, Lahni P, Odoms K, et al Extracellular heat shock protein 60 (Hsp60) levels in children with septic shock Inflamm Res 2007:56(5):216-219 58 Zhang Q, Raoof M, Chen Y, et al Circulating mitochondrial DAMPs cause inflammatory responses to injury Nature 2010:464(7285):104-107 59 Ley K, Laudanna C, Cybulsky MI, Nourshargh S Getting to the site of inflammation: the leukocyte adhesion cascade updated Nat Rev Immunol 2007:7(9):678-689 60 Palmer RM, Ferrige AG, Moncada S Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor Nature 1987:327(6122):524-526 61 Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide Proc Natl Acad Sci U S A 1987: 84(24):9265-9269 62 Moncada S, Higgs EA Nitric oxide and the vascular endothelium Handb Exp Pharmacol 2006(176 Pt 1):213-254 63 Wong HR, Carcillo JA, Burckart G, Shah N, Janosky JE Increased serum nitrite and nitrate concentrations in children with the sepsis syndrome Crit Care Med 1995:23(5):835-842 64 Wong HR, Carcillo JA, Burckart G, Kaplan SS Nitric oxide production in critically ill patients Arch Dis Child 1996:74(6):482-489 65 Vincent JL, Zhang H, Szabo C, Preiser JC Effects of nitric oxide in septic shock Am J Respir Crit Care Med 2000:161(6):1781-1785 66 Levi M, de Jonge E, van der Poll T Sepsis and disseminated intravascular coagulation J Thromb Thrombolysis 2003:16(1-2):43-47 67 Wang L, Bastarache JA, Ware LB The coagulation cascade in sepsis Curr Pharm Des 2008:14(19):1860-1869 68 Hermans PW, Hibberd ML, Booy R, et al 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease Meningococcal Research Group Lancet 1999:354(9178):556-560 69 Kornelisse RF, Hazelzet JA, Savelkoul HF, et al The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock J Infect Dis 1996:173(5):1148-1156 70 Levi M, van der Poll T Recombinant human activated protein C: current insights into its mechanism of action Crit Care 2007:11(suppl 5):S3 71 Nadel S, Goldstein B, Williams MD, et al Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial Lancet 2007:369(9564):836-843 72 Ranieri VM, Thompson BT, Barie PS, et al Drotrecogin alfa (activated) in adults with septic shock N Engl J Med 2012:366(22): 2055-2064 73 Nguyen TC, Carcillo JA Bench-to-bedside review: thrombocytopenia-associated multiple organ failure—a newly appreciated syndrome in the critically ill Crit Care 2006:10(6):235 74 Nguyen TC, Han YY, Kiss JE, et al Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure Crit Care Med 2008:36(10):2878-2887 75 Fortenberry JD, Nguyen T, Grunwell JR, et al Therapeutic plasma exchange in children with thrombocytopenia-associated multiple organ failure: the thrombocytopenia-associated multiple organ failure network prospective experience Crit Care Med 2019:47(3): e173-e181 76 Zingarelli B, Cook JA Peroxisome proliferator-activated receptorgamma is a new therapeutic target in sepsis and inflammation Shock 2005:23(5):393-399 77 Chima RS, Hake PW, Piraino G, Mangeshkar P, Denenberg A, Zingarelli B Ciglitazone ameliorates lung inflammation by modulating the inhibitor kappaB protein kinase/nuclear factorkappaB pathway after hemorrhagic shock Crit Care Med 2008: 36(10):2849-2857 78 Zingarelli B, Hake PW, O’Connor M, et al Lung injury after hemorrhage is age dependent: role of peroxisome proliferator-activated receptor gamma Crit Care Med 2009:37(6):1978-1987 79 Kuboki S, Shin T, Huber N, et al Peroxisome proliferator-activated receptor-gamma protects against hepatic ischemia/reperfusion injury in mice Hepatology 2008:47(1):215-224 80 Kaplan JM, Cook JA, Hake PW, O’Connor M, Burroughs TJ, Zingarelli B 15-Deoxy-delta(12,14)-prostaglandin J(2) (15DPGJ(2)), a peroxisome proliferator activated receptor gamma ligand, reduces tissue leukosequestration and mortality in endotoxic shock Shock 2005:24(1):59-65 81 Zingarelli B, Sheehan M, Hake PW, O’Connor M, Denenberg A, Cook JA Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-delta(12,14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways J Immunol 2003:171(12):6827-6837 82 Slinko S, Piraino G, Hake PW, et al Combined zinc supplementation with proinsulin C-peptide treatment decreases the inflammatory response and mortality in murine polymicrobial sepsis Shock 2014:41(4):292-300 83 Kaplan JM, Denenberg A, Monaco M, Nowell M, Wong H, Zingarelli B Changes in peroxisome proliferator-activated receptorgamma activity in children with septic shock Intensive Care Med 2010;36(1):123–130 84 Kaplan JM, Zingarelli B, Krallman K, et al Phase safety and pharmacokinetic study on the use of pioglitazone in critically ill patients with sepsis: a randomized clinical trial Intensive Care Med 2018;44(11):2006-2008 85 Gabrilovich DI, Nagaraj S Myeloid-derived suppressor cells as regulators of the immune system Nat Rev Immunol 2009:9(3):162-174 86 Derive M, Bouazza Y, Alauzet C, Gibot S Myeloid-derived suppressor cells control microbial sepsis Intensive Care Med 2012:38(6): 1040-1049 87 Cuenca AG, Delano MJ, Kelly-Scumpia KM, et al A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma Mol Med 2011:17(3-4):281-292 88 Cuenca AG, Moldawer LL Myeloid-derived suppressor cells in sepsis: friend or foe? Intensive Care Med 2012:38(6):928-930 89 Munford RS, Pugin J Normal responses to injury prevent systemic inflammation and can be immunosuppressive Am J Respir Crit Care Med 2001:163(2):316-321 e3 90 Mahidhara R, Billiar TR Apoptosis in sepsis Crit Care Med 2000:28(4 suppl):N105-N113 91 Volk HD, Reinke P, Krausch D, et al Monocyte deactivation— rationale for a new therapeutic strategy in sepsis Intensive Care Med 1996:22(suppl 4):S474-S481 92 Docke WD, Randow F, Syrbe U, et al Monocyte deactivation in septic patients: restoration by IFN-gamma treatment Nat Med 1997:3(6):678-681 93 Heidecke CD, Hensler T, Weighardt H, et al Selective defects of T lymphocyte function in patients with lethal intraabdominal infection Am J Surg 1999:178(4):288-292 94 Felmet KA, Hall MW, Clark RS, Jaffe R, Carcillo JA Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure J Immunol 2005:174(6):3765-3772 95 Muszynski JA, Nofziger R, Greathouse K, et al Early adaptive immune suppression in children with septic shock: a prospective observational study Crit Care 2014:18(4):R145 96 Hotchkiss RS, Swanson PE, Knudson CM, et al Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis J Immunol 1999:162(7):4148-4156 97 Wynn JL, Scumpia PO, Winfield RD, et al Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists Blood 2008:112(5):1750-1758 98 Wesche DE, Lomas-Neira JL, Perl M, Chung CS, Ayala A Leukocyte apoptosis and its significance in sepsis and shock J Leukoc Biol 2005:78(2):325-337 99 Chung CS, Song GY, Lomas J, Simms HH, Chaudry IH, Ayala A Inhibition of Fas/Fas ligand signaling improves septic survival: differential effects on macrophage apoptotic and functional capacity J Leukoc Biol 2003:74(3):344-351 100 Chang KC, Unsinger J, Davis CG, et al Multiple triggers of cell death in sepsis: death receptor and mitochondrial-mediated apoptosis Faseb J 2007:21(3):708-719 101 Unsinger J, Herndon JM, Davis CG, Muenzer JT, Hotchkiss RS, Ferguson TA The role of TCR engagement and activation-induced cell death in sepsis-induced T cell apoptosis J Immunol 2006:177(11):7968-7973 102 Schwulst SJ, Grayson MH, DiPasco PJ, et al Agonistic monoclonal antibody against CD40 receptor decreases lymphocyte apoptosis and improves survival in sepsis J Immunol 2006:177(1):557-565 103 Hotchkiss RS, McConnell KW, Bullok K, et al TAT-BH4 and TAT-Bcl-xL peptides protect against sepsis-induced lymphocyte apoptosis in vivo J Immunol 2006:176(9):5471-5477 104 Hotchkiss RS, Osmon SB, Chang KC, Wagner TH, Coopersmith CM, Karl IE Accelerated lymphocyte death in sepsis occurs by both the death receptor and mitochondrial pathways J Immunol 2005:174(8):5110-5118 105 Scumpia PO, Delano MJ, Kelly KM, et al Increased natural CD41CD251 regulatory T cells and their suppressor activity not contribute to mortality in murine polymicrobial sepsis J Immunol 2006:177(11):7943-7949 106 Hotchkiss RS, Swanson PE, Freeman BD, et al Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction Crit Care Med 1999:27(7):1230-1251 107 Monserrat J, de Pablo R, Prieto A, Reyes E, Alvarez-Mon M Using surface molecule expression on lymphocytes to classify septic shock patients Crit Care 2009:13(3):412 108 Wen H, Dou Y, Hogaboam CM, Kunkel SL Epigenetic regulation of dendritic cell-derived interleukin-12 facilitates immunosuppression after a severe innate immune response Blood 2008:111(4):1797-1804 109 Wen H, Schaller MA, Dou Y, Hogaboam CM, Kunkel SL Dendritic cells at the interface of innate and acquired immunity: the role for epigenetic changes J Leukoc Biol 2008:83(3):439-446 110 Hotchkiss RS, Colston E, Yende S, et al Immune checkpoint inhibition in sepsis: a phase 1b randomized, placebo-controlled, single ascending dose study of antiprogrammed cell death-ligand antibody (BMS-936559) Crit Care Med 2019:47(5):632-642 111 Cooke GS, Hill AV Genetics of susceptibility to human infectious disease Nat Rev Genet 2001:2(12):967-977 112 Sorensen TI, Nielsen GG, Andersen PK, Teasdale TW Genetic and environmental influences on premature death in adult adoptees N Engl J Med 1988:318(12):727-732 113 Arcaroli J, Fessler MB, Abraham E Genetic polymorphisms and sepsis Shock 2005:24(4):300-312 114 Waterer GW, Wunderink RG Science review: Genetic variability in the systemic inflammatory response Crit Care 2003:7(4):308-314 115 Holmes CL, Russell JA, Walley KR Genetic polymorphisms in sepsis and septic shock: role in prognosis and potential for therapy Chest 2003:124(3):1103-1115 116 Stuber F, Klaschik S, Lehmann LE, Schewe JC, Weber S, Book M Cytokine promoter polymorphisms in severe sepsis Clin Infect Dis 2005:41(suppl 7):S416-S420 117 Arbour NC, Lorenz E, Schutte BC, et al TLR4 mutations are associated with endotoxin hyporesponsiveness in humans Nat Genet 2000:25(2):187-191 118 Schwartz DA: The role of TLR4 in endotoxin responsiveness in humans J Endotoxin Res 2001:7(5):389-393 119 Lorenz E, Mira JP, Frees KL, Schwartz DA Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock Arch Intern Med 2002:162(9):1028-1032 120 Agnese DM, Calvano JE, Hahm SJ, et al Human toll-like receptor mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections J Infect Dis 2002:186(10):15221525 121 Barber RC, Chang LY, Arnoldo BD, et al Innate immunity SNPs are associated with risk for severe sepsis after burn injury Clin Med Res 2006:4(4):250-255 122 Karoly E, Fekete A, Banki NF, et al Heat shock protein 72 (HSPA1B) gene polymorphism and Toll-like receptor (TLR) mutation are associated with increased risk of urinary tract infection in children Pediatr Res 2007:61(3):371-374 123 Read RC, Pullin J, Gregory S, et al A functional polymorphism of toll-like receptor is not associated with likelihood or severity of meningococcal disease J Infect Dis 2001:184(5):640-642 124 Allen A, Obaro S, Bojang K, et al Variation in Toll-like receptor and susceptibility to group A meningococcal meningitis in Gambian children Pediatr Infect Dis J 2003:22(11):1018-1019 125 Hubacek JA, Stuber F, Frohlich D, et al The common functional C(-159)T polymorphism within the promoter region of the lipopolysaccharide receptor CD14 is not associated with sepsis development or mortality Genes Immun 2000:1(6):405-407 126 Gibot S, Cariou A, Drouet L, Rossignol M, Ripoll L Association between a genomic polymorphism within the CD14 locus and septic shock susceptibility and mortality rate Crit Care Med 2002;30(5):969-973 127 Heesen M, Bloemeke B, Schade U, Obertacke U, Majetschak M The -260 C—.T promoter polymorphism of the lipopolysaccharide receptor CD14 and severe sepsis in trauma patients Intensive Care Med 2002:28(8):1161-1163 128 Gu W, Shan YA, Zhou J, et al Functional significance of gene polymorphisms in the promoter of myeloid differentiation-2 Ann Surg 2007:246(1):151-158 129 Kutukculer N, Yeniay BS, Aksu G, Berdeli A Arg753Gln polymorphism of the human toll-like receptor-2 gene in children with recurrent febrile infections Biochem Genet 2007:45(7-8):507-514 130 Tabel Y, Berdeli A, Mir S Association of TLR2 gene Arg753Gln polymorphism with urinary tract infection in children Int J Immunogenet 2007:34(6):399-405 131 Lorenz E, Mira JP, Cornish KL, Arbour NC, Schwartz DA A novel polymorphism in the toll-like receptor gene and its potential association with staphylococcal infection Infect Immun 2000:68(11): 6398-6401 132 Whitmore LC, Hook JS, Philiph AR, et al A common genetic variant in TLR1 enhances human neutrophil priming and impacts length of intensive care stay in pediatric sepsis J Immunol 2016:196(3):1376-1386 e4 133 van Deventer SJ Cytokine and cytokine receptor polymorphisms in infectious disease Intensive Care Med 2000:26(suppl 1):S98S102 134 Mira JP, Cariou A, Grall F, et al Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study JAMA 1999:282(6):561-568 135 Nadel S, Newport MJ, Booy R, Levin M Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease J Infect Dis 1996:174(4):878-880 136 McArthur JA, Zhang Q, Quasney MW Association between the A/A genotype at the lymphotoxin-alpha1250 site and increased mortality in children with positive blood cultures Pediatr Crit Care Med 2002:3(4):341-344 137 Read RC, Cannings C, Naylor SC, et al Variation within genes encoding interleukin-1 and the interleukin-1 receptor antagonist influence the severity of meningococcal disease Ann Intern Med 2003:138(7):534-541 138 Endler G, Marculescu R, Starkl P, et al Polymorphisms in the interleukin-1 gene cluster in children and young adults with systemic meningococcemia Clin Chem 2006:52(3):511-514 139 Lehrnbecher T, Bernig T, Hanisch M, et al Common genetic variants in the interleukin-6 and chitotriosidase genes are associated with the risk for serious infection in children undergoing therapy for acute myeloid leukemia Leukemia 2005:19(10):1745-1750 140 Michalek J, Svetlikova P, Fedora M, et al Interleukin-6 gene variants and the risk of sepsis development in children Hum Immunol 2007:68(9):756-760 141 Balding J, Healy CM, Livingstone WJ, et al Genomic polymorphic profiles in an Irish population with meningococcaemia: is it possible to predict severity and outcome of disease? Genes Immun 2003:4(8):533-540 142 Artifoni L, Negrisolo S, Montini G, et al Interleukin-8 and CXCR1 receptor functional polymorphisms and susceptibility to acute pyelonephritis J Urol 2007:177(3):1102-1106 143 Westendorp RG, Hottenga JJ, Slagboom PE Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock Lancet 1999:354(9178):561-563 144 Haralambous E, Hibberd ML, Hermans PW, Ninis N, Nadel S, Levin M Role of functional plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism in susceptibility, severity, and outcome of meningococcal disease in Caucasian children Crit Care Med 2003:31(12):2788-2793 145 Geishofer G, Binder A, Muller M, et al 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia Eur J Pediatr 2005: 164(8):486-490 146 Binder A, Endler G, Rieger S, et al Protein C promoter polymorphisms associate with sepsis in children with systemic meningococcemia Hum Genet 2007:122(2):183-190 147 van Sorge NM, van der Pol WL, van de Winkel JG FcgammaR polymorphisms: Implications for function, disease susceptibility and immunotherapy Tissue Antigens 2003:61(3):189-202 148 Bredius RG, Derkx BH, Fijen CA, et al Fc gamma receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children J Infect Dis 1994:170(4):848-853 149 Domingo P, Muniz-Diaz E, Baraldes MA, et al Associations between Fc gamma receptor IIA polymorphisms and the risk and prognosis of meningococcal disease Am J Med 2002:112(1):19-25 150 Platonov AE, Kuijper EJ, Vershinina IV, et al Meningococcal disease and polymorphism of FcgammaRIIa (CD32) in late complement component-deficient individuals Clin Exp Immunol 1998:111(1):97-101 151 Drogari-Apiranthitou M, Fijen CA, Thiel S, et al The effect of mannan-binding lectin on opsonophagocytosis of Neisseria meningitidis Immunopharmacology 1997:38(1-2):93-99 152 van der Pol WL, Huizinga TW, Vidarsson G, et al Relevance of Fcgamma receptor and interleukin-10 polymorphisms for meningococcal disease J Infect Dis 2001:184(12):1548-1555 153 Fijen CA, Bredius RG, Kuijper EJ Polymorphism of IgG Fc receptors in meningococcal disease Ann Intern Med 1993:119(7 Pt 1):636 154 Yee AM, Phan HM, Zuniga R, Salmon JE, Musher DM Association between FcgammaRIIa-R131 allotype and bacteremic pneumococcal pneumonia Clin Infect Dis 2000:30(1):25-28 155 Yuan FF, Wong M, Pererva N, et al FcgammaRIIA polymorphisms in Streptococcus pneumoniae infection Immunol Cell Biol 2003:81(3):192-195 156 Summerfield JA, Sumiya M, Levin M, Turner MW Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series BMJ 1997:314(7089): 1229-1232 157 Hibberd ML, Sumiya M, Summerfield JA, Booy R, Levin M Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease Meningococcal Research Group Lancet 1999:353(9158):1049-1053 158 Koch A, Melbye M, Sorensen P, et al Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood JAMA 2001:285(10):1316-1321 159 Gomi K, Tokue Y, Kobayashi T, et al Mannose-binding lectin gene polymorphism is a modulating factor in repeated respiratory infections Chest 2004:126(1):95-99 160 Roy S, Knox K, Segal S, et al MBL genotype and risk of invasive pneumococcal disease: a case-control study Lancet 2002:359(9317): 1569-1573 161 Fidler KJ, Wilson P, Davies JC, Turner MW, Peters MJ, Klein NJ Increased incidence and severity of the systemic inflammatory response syndrome in patients deficient in mannose-binding lectin Intensive Care Med 2004:30(7):1438-1445 162 Michalek J, Svetlikova P, Fedora M, et al Bactericidal permeability increasing protein gene variants in children with sepsis Intensive Care Med 2007:33(12):2158-2164 163 Levin M, Quint PA, Goldstein B, et al Recombinant bactericidal/ permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial rBPI21 Meningococcal Sepsis Study Group Lancet 2000:356(9234): 961-967 164 Stalets E, Wong HR Critically associating Crit Care Med 2009:37(4): 1492-1493 165 Maslove DM, Wong HR Gene expression profiling in sepsis: timing, tissue, and translational considerations Trends Mol Med 2014: 20(4):204-213 166 Wong HR Clinical review: sepsis and septic shock—the potential of gene arrays Crit Care 2012:16(1):204 167 Wong HR Genome-wide expression profiling in pediatric septic shock Pediatr Res 2013:73(4 Pt 2):564-569 168 Wong HR, Shanley TP, Sakthivel B, et al Genome-level expression profiles in pediatric septic shock indicate a role for altered zinc homeostasis in poor outcome Physiol Genomics 2007:30(2):146-155 169 Cvijanovich N, Shanley TP, Lin R, et al Validating the genomic signature of pediatric septic shock Physiol Genomics 2008: 34(1):127-134 170 Shanley TP, Cvijanovich N, Lin R, et al Genome-level longitudinal expression of signaling pathways and gene networks in pediatric septic shock Mol Med 2007:13(9-10):495-508 171 Wong HR, Cvijanovich N, Allen GL, et al Genomic expression profiling across the pediatric systemic inflammatory response syndrome, sepsis, and septic shock spectrum Crit Care Med 2009: 37(5):1558-1566 172 Wynn JL, Cvijanovich NZ, Allen GL, et al The influence of developmental age on the early transcriptomic response of children with septic shock Mol Med 2011:17(11-12):1146-1156 173 Weiss SL, Cvijanovich NZ, Allen GL, et al Differential expression of the nuclear-encoded mitochondrial transcriptome in pediatric septic shock Crit Care 2014:18(6):623 174 Wong HR, Cvijanovich NZ, Allen GL, et al Corticosteroids are associated with repression of adaptive immunity gene programs in pediatric septic shock Am J Respir Crit Care Med 2014:189(8):940-946 e5 174a Jardine D, Emond M, Meert KL, et al A single nucleotide polymorphism in the corticotropin receptor gene is associated with a blunted cortisol response during pediatric critical illness Pediatr Crit Care Med 2014;15(8):698–705 175 Nowak JE, Harmon K, Caldwell CC, Wong HR Prophylactic zinc supplementation reduces bacterial load and improves survival in a murine model of sepsis Pediatr Crit Care Med 2012:13(5): e323-e329 176 Cvijanovich NZ, King JC, Flori HR, Gildengorin G, Vinks AA, Wong HR A safety and dose escalation study of intravenous zinc supplementation in pediatric critical illness JPEN J Parenter Enteral Nutr 2016;40(6):860–868 177 Wong HR, Cvijanovich N, Lin R, et al Identification of pediatric septic shock subclasses based on genome-wide expression profiling BMC Med 2009:7:34 178 Wong HR, Wheeler DS, Tegtmeyer K, et al Toward a clinically feasible gene expression-based subclassification strategy for septic shock: proof of concept Crit Care Med 2010:38(10): 1955-1961 179 Wong HR, Cvijanovich NZ, Allen GL, et al Validation of a gene expression-based subclassification strategy for pediatric septic shock Crit Care Med 2011:39(11):2511-2517 180 Standage SW, Caldwell CC, Zingarelli B, Wong HR Reduced peroxisome proliferator-activated receptor alpha expression is associated with decreased survival and increased tissue bacterial load in sepsis Shock 2012:37(2):164-169 181 Standage SW, Bennion BG, Knowles TO, et al PPARalpha augments heart function and cardiac fatty acid oxidation in early experimental polymicrobial sepsis Am J Physiol Heart Circ Physiol 2017:312(2):H239-H249 182 Iwaki T, Bennion BG, Stenson EK, et al PPARalpha contributes to protection against metabolic and inflammatory derangements associated with acute kidney injury in experimental sepsis Physiol Rep 2019,: 7(10):e14078 183 Solan PD, Dunsmore KE, Denenberg AG, Odoms K, Zingarelli B, Wong HR A novel role for matrix metalloproteinase-8 in sepsis Crit Care Med 2012:40(2):379-387 184 Fink MP Matrix metalloproteinase-8 as a potential drug target for the therapy of sepsis Crit Care Med 2012:40(2):655-656 185 Alder MN, Opoka AM, Lahni P, Hildeman DA, Wong HR Olfactomedin-4 is a candidate marker for a pathogenic neutrophil subset in septic shock Crit Care Med 2017:45(4):e426-e432 186 Alder MN, Mallela J, Opoka AM, Lahni P, Hildeman DA, Wong HR Olfactomedin marks a subset of neutrophils in mice Innate Immun 2019:25(1):22-33 187 Wong HR, Cvijanovich NZ, Hall M, et al Interleukin-27 is a novel candidate diagnostic biomarker for bacterial infection in critically ill children Crit Care 2012:16(5):R213 188 Basu RK, Standage SW, Cvijanovich NZ, et al Identification of candidate serum biomarkers for severe septic shock-associated kidney injury via microarray Crit Care 2011:15(6):R273 189 Wong HR, Cvijanovich NZ, Anas N, et al A multi-biomarkerbased model for estimating the risk of septic acute kidney injury Crit Care Med 2015;43(8):1646–1653 190 Wong HR, Salisbury S, Xiao Q, et al The pediatric sepsis biomarker risk model Crit Care 2012:16(5):R174 191 Wong HR, Weiss SL, Giuliano JS Jr, et al Testing the prognostic accuracy of the updated pediatric sepsis biomarker risk model PloS One 2014:9(1):e86242 192 Wong HR, Weiss SL, Giuliano JS Jr, et al The temporal version of the pediatric sepsis biomarker risk model PloS One 2014:9(3):e92121 193 Wong HR, Lindsell CJ, Pettila V, et al A multibiomarker-based outcome risk stratification model for adult septic shock* Crit Care Med 2014:42(4):781-789 194 Alder MN, Lindsell CJ, Wong HR The pediatric sepsis biomarker risk model: potential implications for sepsis therapy and biology Expert Rev Anti Infect Ther 2014:12(7):809-816 195 Wong HR, Walley KR, Pettila V, et al Comparing the prognostic performance of ASSIST to interleukin-6 and procalcitonin in patients with severe sepsis or septic shock Biomarkers 2015:1-4 196 Lotvall J, Akdis CA, Bacharier LB, et al Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome J Allergy Clin Immunol 2011:127(2):355-360 197 Wong HR, Cvijanovich NZ, Anas N, et al Developing a clinically feasible personalized medicine approach to pediatric septic shock Am J Respir Crit Care Med 2015:191(3):309-315 198 Kavanagh BP, Suffredini AF Management of pediatric septic shock Progress through applied insight Am J Respir Crit Care Med 2015: 191(3):247-248 199 Hutchins NA, Unsinger J, Hotchkiss RS, Ayala A The new normal: immunomodulatory agents against sepsis immune suppression Trends Molecular Medicine 2014:20(4):224-233 200 Atkinson SJ, Wong HR Identifying critically ill patients who may benefit from adjunctive corticosteroids: not as easy as we thought Pediatr Crit Care Med 2014:15(8):769-771 201 Scicluna BP, van Vught LA, Zwinderman AH, et al Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study Lancet Respir Med 2017:5(10): 816-826 202 Davenport EE, Burnham KL, Radhakrishnan J, et al Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study Lancet Respir Med 2016:4(4): 259-271 203 Sweeney TE, Azad TD, Donato M, et al Unsupervised analysis of transcriptomics in bacterial sepsis across multiple datasets reveals three robust clusters Crit Care Med 2018:46(6):915-925 204 Davis AL, Carcillo JA, Aneja RK, et al American College of Critical Care Medicine Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock Crit Care Med 2017:45(6):1061-1093 205 Brierley J, Carcillo JA, Choong K, et al Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine Crit Care Med 2009:37(2):666-688 206 Carcillo JA, Davis AL, Zaritsky A Role of early fluid resuscitation in pediatric septic shock JAMA 1991:266(9):1242-1245 207 Han YY, Carcillo JA, Dragotta MA, et al Early reversal of pediatric-neonatal septic shock by community physicians is associated with improved outcome Pediatrics 2003:112(4):793-799 208 Oliveira CF, Nogueira de Sa FR, Oliveira DS, et al Time- and fluid-sensitive resuscitation for hemodynamic support of children in septic shock: barriers to the implementation of the American College of Critical Care Medicine/Pediatric Advanced Life Support Guidelines in a pediatric intensive care unit in a developing world Pediatr Emerg Care 2008:24(12):810-815 209 Hilton AK, Bellomo R A critique of fluid bolus resuscitation in severe sepsis Crit Care 2012:16(1):302 210 Boyd JH, Forbes J, Nakada TA, Walley KR, Russell JA Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality Crit Care Med 2011:39(2):259-265 211 Goldstein SL, Somers MJ, Baum MA, et al Pediatric patients with multi-organ dysfunction syndrome receiving continuous renal replacement therapy Kidney Int 2005:67(2):653-658 212 Murphy CV, Schramm GE, Doherty JA, et al The importance of fluid management in acute lung injury secondary to septic shock Chest 2009:136(1):102-109 213 Vincent JL, Sakr Y, Sprung CL, et al Sepsis in European intensive care units: results of the SOAP study Crit Care Med 2006:34(2): 344-353 214 Sutherland SM, Zappitelli M, Alexander SR, et al Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry Am J Kidney Dis 2010:55(2):316-325 ... component-deficient individuals Clin Exp Immunol 1998:111(1):97-101 151 Drogari-Apiranthitou M, Fijen CA, Thiel S, et al The effect of mannan-binding lectin on opsonophagocytosis of Neisseria... Gibot S, Cariou A, Drouet L, Rossignol M, Ripoll L Association between a genomic polymorphism within the CD14 locus and septic shock susceptibility and mortality rate Crit Care Med 2002;30(5):969-973... cultures Pediatr Crit Care Med 2002:3(4):341-344 137 Read RC, Cannings C, Naylor SC, et al Variation within genes encoding interleukin-1 and the interleukin-1 receptor antagonist influence the severity